Zusammenfassung
Primäre Kopfschmerzerkrankungen können sich hinsichtlich ihrer klinischen Symptome über die Lebensspanne eines Menschen verändern und in ihrer Ausprägung und Frequenz deutlich fluktuieren. Vor der Pubertät sind Jungen und Mädchen gleich häufig betroffen. Nach der Pubertät sind es in aller Regel vor allem die Frauen. Die Behandlung primärer Kopfschmerzerkrankungen erfolgt stets unter Berücksichtigung der Schwere und Häufigkeit der Kopfschmerzattacken sowie begleitender Komorbiditäten. Mittels vorbeugender Maßnahmen können Kopfschmerzverläufe moduliert werden. Eine gezielte Prophylaxe ist der wichtigste Ansatz, um eine Schmerzchronifizierung durch Übergebrauch von Medikamenten zu verhindern. Während sich primäre Kopfschmerzerkrankungen im höheren Lebensalter meist abschwächen, nehmen die sekundären Kopfschmerzerkrankungen mit dem Alter eher zu. Sie sind oft Ausdruck einer onkologischen oder vaskulären Erkrankung oder Nebenwirkung von Medikamenten. Ihre Behandlung und Prognose richtet sich stets nach der zugrunde liegenden Erkrankung.
Abstract
Symptoms and signs of primary headache disorders can change during one’s lifetime. Moreover, the impact and the frequency of attacks can fluctuate in an individual patient over time. Before puberty, boys and girls are equally affected; after puberty most headache disorders predominate in women. The treatment of primary headache disorders always has to take into consideration the severity and the frequency of headache attacks as well as the relevant comorbidities. Prophylactic headache treatment can modulate the course of primary headache disorders. Specific prophylactic treatment is the most important instrument for avoiding headache chronification caused by medication overuse. While primary headache disorders tend to improve in elderly patients, secondary headache disorders peak in elderly people. They are often a symptom of oncologic diseases, vascular disorders, or are linked to side effects of drugs that are prescribed more frequently in the elderly. The treatment and the prognosis of secondary headache disorders always depend on the underlying disease.
Literatur
Tonini MC, Bussone G (2010) Headache in the elderly: primary forms. Neurol Sci 31(Suppl 1):S67–S71
Straube A, Hinz B, Kropp P, Förderreuther S, Lampl C, Sandor P, May A, Haag G (2012) Kopf- und Gesichtsschmerzen im Alter. Nervenheilkunde 31:733–757
Prencipe M, Casini AR, Ferretti C, Santini M, Pezzella F, Scaldaferri N, Culasso F (2001) Prevalence of headache in an elderly population: attack frequency, disability, and use of medication. J Neurol Neurosurg Psychiatry 70:377–381
Bigal ME, Lipton RB (2008) Excessive acute migraine medication use and migraine progression. Neurology 71:1821–1828
Bigal ME, Lipton RB (2009) What predicts the change from episodic to chronic migraine? Curr Opin Neurol 22:269–276
Crystal SC, Robbins MS (2010) Epidemiology of tension-type headache. Curr Pain Headache Rep 14:449–454
Sahler K (2012) Epidemiology and cultural differences in tension-type headache. Curr Pain Headache Rep 16:525–532
Pfaffenrath V, Fendrich K, Vennemann M, Meisinger C, Ladwig KH, Evers S, Straube A, Hoffmann W, Berger K (2009) Regional variations in the prevalence of migraine and tension-type headache applying the new IHS criteria: the German DMKG Headache Study. Cephalalgia 29:48–57
Fendrich K, Vennemann M, Pfaffenrath V, Evers S, May A, Berger K, Hoffmann W (2007) Headache prevalence among adolescents–the German DMKG headache study. Cephalalgia 27:347–354
Stovner LJ, Andree C (2010) Prevalence of headache in Europe: a review for the Eurolight project. J Headache Pain 11:289–299
Russell MB, Levi N, Saltyte-Benth J, Fenger K (2006) Tension-type headache in adolescents and adults: a population based study of 33,764 twins. Eur J Epidemiol 21:153–160
Kaniecki RG (2007) Tension-type Headache in the Elderly. Curr Treat Options Neurol 9:31–37
Schwaiger J, Kiechl S, Seppi K, Sawires M, Stockner H, Erlacher T, Mairhofer ML, Niederkofler H, Rungger G, Gasperi A, Poewe W, Willeit J (2009) Prevalence of primary headaches and cranial neuralgias in men and women aged 55–94 years (Bruneck Study). Cephalalgia 29:179–187
Rasmussen BK (1993) Migraine and tension-type headache in a general population: precipitating factors, female hormones, sleep pattern and relation to lifestyle. Pain 53:65–72
Spierings EL, Ranke AH, Honkoop PC (2001) Precipitating and aggravating factors of migraine versus tension-type headache. Headache 41:554–558
Zivadinov R, Willheim K, Sepic-Grahovac D, Jurjevic A, Bucuk M, Brnabic-Razmilic O, Relja G, Zorzon M (2003) Migraine and tension-type headache in Croatia: a population-based survey of precipitating factors. Cephalalgia 23:336–343
Haque B, Rahman KM, Hoque A, Hasan AT, Chowdhury RN, Khan SU, Alam MB, Habib M, Mohammad QD (2012) Precipitating and relieving factors of migraine versus tension type headache. BMC Neurol 12:82
Haag G, Diener HC, May A, Meyer C, Morck H, Straube A, Wessely P, Evers S, DMKG, DGN, OKSG, SKG (2011) Self-medication of migraine and tension-type headache: summary of the evidence-based recommendations of the Deutsche Migrane und Kopfschmerzgesellschaft (DMKG), the Deutsche Gesellschaft fur Neurologie (DGN), the Osterreichische Kopfschmerzgesellschaft (OKSG) and the Schweizerische Kopfwehgesellschaft (SKG). J Headache Pain 12:201–217
Straube A, May A, Kropp P, Katsarava Z, Haag G, Lampl C, Sandor PS, Diener HC, Evers S (2008) Therapy of primary chronic headache: chronic migraine, chronic tension type headache and other forms of daily chronic headache. Schmerz 22:531–534, 536–540, 542–533
Headache Classification Committee of the International Headache S (2013) The international classification of headache disorders, 3rd edition (beta version). Cephalalgia 33:629–808
Gelfand AA (2013) Migraine and childhood periodic syndromes in children and adolescents. Curr Opin Neurol 26:262–268
Buse DC, Loder EW, Gorman JA, Stewart WF, Reed ML, Fanning KM, Serrano D, Lipton RB (2013) Sex differences in the prevalence, symptoms, and associated features of migraine, probable migraine and other severe headache: results of the American Migraine Prevalence and Prevention (AMPP) Study. Headache 53:1278–1299
Merikangas KR (2013) Contributions of epidemiology to our understanding of migraine. Headache 53:230–246
Stewart WF, Lipton RB, Celentano DD, Reed ML (1992) Prevalence of migraine headache in the United States. Relation to age, income, race, and other sociodemographic factors. JAMA 267:64–69
Tepper SJ (2008) A pivotal moment in 50 years of headache history: the first American migraine study. Headache 48:730–731 (discussion 732)
Vetvik KG, MacGregor EA, Lundqvist C, Russell MB (2010) Self-reported menstrual migraine in the general population. J Headache Pain 11:87–92
Vetvik KG, Macgregor EA, Lundqvist C, Russell MB (2014) Prevalence of menstrual migraine: a population- based study. Cephalalgia 34:280–288
Pringsheim T, Davenport WJ, Dodick D (2008) Acute treatment and prevention of menstrually related migraine headache: evidence-based review. Neurology 70:1555–1563
MacGregor EA (2010) Prevention and treatment of menstrual migraine. Drugs 70:1799–1818
Scharff L, Marcus DA, Turk DC (1997) Headache during pregnancy and in the postpartum: a prospective study. Headache 37:203–210
Marcus DA, Scharff L, Turk D (1999) Longitudinal prospective study of headache during pregnancy and postpartum. Headache 39:625–632
Sances G, Granella F, Nappi RE, Fignon A, Ghiotto N, Polatti F, Nappi G (2003) Course of migraine during pregnancy and postpartum: a prospective study. Cephalalgia 23:197–205
Torelli P, Allais G, Manzoni GC (2010) Clinical review of headache in pregnancy. Neurol Sci 31(Suppl 1):S55–S58
Digre KB (2013) Headaches during pregnancy. Clin Obstet Gynecol 56:317–329
Dahlof CG, Johansson M, Casserstedt S, Motallebzadeh T (2009) The course of frequent episodic migraine in a large headache clinic population: a 12-year retrospective follow-up study. Headache 49:1144–1152
Neut D, Fily A, Cuvellier JC, Vallee L (2012) The prevalence of triggers in paediatric migraine: a questionnaire study in 102 children and adolescents. J Headache Pain 13:61–65
Baldacci F, Vedovello M, Ulivi M, Vergallo A, Poletti M, Borelli P, Cipriani G, Nuti A, Bonuccelli U (2013) Triggers in allodynic and non-allodynic migraineurs. A clinic setting study. Headache 53:152–160
Lipton RB (2011) Chronic migraine, classification, differential diagnosis, and epidemiology. Headache 51(Suppl 2):77–83
Negro A, Martelletti P (2011) Chronic migraine plus medication overuse headache: two entities or not? J Headache Pain 12:593–601
Curone M, Tullo V, Savino M, Proietti-Cecchini A, Bussone G, D’Amico D (2013) Outcome of patients with chronic migraine with medication overuse and depression after duloxetine: influence of coexisting obsessive compulsive disorder. Neurol Sci 34(Suppl 1):175–177
Evans RW (2013) A rational approach to the management of chronic migraine. Headache 53:168–176
Manack A, Buse DC, Serrano D, Turkel CC, Lipton RB (2011) Rates, predictors, and consequences of remission from chronic migraine to episodic migraine. Neurology 76:711–718
Grazzi L, Usai S, Prunesti A, Bussone G, Andrasik F (2009) Behavioral plus pharmacological treatment versus pharmacological treatment only for chronic migraine with medication overuse after day-hospital withdrawal. Neurol Sci 30(Suppl 1):S117–119
Gunreben-Stempfle B, Griessinger N, Lang E, Muehlhans B, Sittl R, Ulrich K (2009) Effectiveness of an intensive multidisciplinary headache treatment program. Headache 49:990–1000
Straube A, Gaul C, Forderreuther S, Kropp P, Marziniak M, Evers S, Jost WH, Gobel H, Lampl C, Sandor PS, Gantenbein AR, Diener HC, German M, Headache S, German Society for N, Austrian Headache S, Swiss Headache S (2012) Therapy and care of patients with chronic migraine: expert recommendations of the German Migraine and Headache Society/German Society for Neurology as well as the Austrian Headache Society/Swiss Headache Society. Nervenarzt 83:1600–1608
Wallasch TM, Angeli A, Kropp P (2012) Outcomes of a headache-specific cross-sectional multidisciplinary treatment program. Headache 52:1094–1105
Fischera M, Marziniak M, Gralow I, Evers S (2008) The incidence and prevalence of cluster headache: a meta-analysis of population-based studies. Cephalalgia 28:614–618
Evers S, Fischera M, May A, Berger K (2007) Prevalence of cluster headache in Germany: results of the epidemiological DMKG study. J Neurol Neurosurg Psychiatry 78:1289–1290
Evers S, Frese A, Majewski A, Albrecht O, Husstedt IW (2002) Age of onset in cluster headache: the clinical spectrum (three case reports). Cephalalgia 22:160–162
Rasmussen B (1999) Epidemiology of cluster headache. In: Olesen J, Goadsby P (Hrsg) Cluster headache and related disorders. Oxford University Press, New York, S 23–26
Manzoni GC, Micieli G, Granella F, Tassorelli C, Zanferrari C, Cavallini A (1991) Cluster headache–course over ten years in 189 patients. Cephalalgia 11:169–174
Paemeleire K, Bahra A, Evers S, Matharu MS, Goadsby PJ (2006) Medication-overuse headache in patients with cluster headache. Neurology 67:109–113
Hering-Hanit R, Gadoth N (2003) Caffeine-induced headache in children and adolescents. Cephalalgia 23:332–335
Kossoff EH, Mankad DN (2006) Medication-overuse headache in children: is initial preventive therapy necessary? J Child Neurol 21:45–48
Limmroth V, Katsarava Z, Fritsche G, Przywara S, Diener HC (2002) Features of medication overuse headache following overuse of different acute headache drugs. Neurology 59:1011–1014
Evers S, Marziniak M (2010) Clinical features, pathophysiology, and treatment of medication-overuse headache. Lancet Neurol 9:391–401
Katsarava Z, Limmroth V, Finke M, Diener HC, Fritsche G (2003) Rates and predictors for relapse in medication overuse headache: a 1-year prospective study. Neurology 60:1682–1683
Gaul C, van Doorn C, Webering N, Dlugaj M, Katsarava Z, Diener HC, Fritsche G (2011) Clinical outcome of a headache-specific multidisciplinary treatment program and adherence to treatment recommendations in a tertiary headache center: an observational study. J Headache Pain 12:475–483
Olesen J (2012) Detoxification for medication overuse headache is the primary task. Cephalalgia 32:420–422
Einhaltung ethischer Richtlinien
Interessenkonflikt
S. Förderreuther gibt an, dass kein Interessenkonflikt besteht.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Förderreuther, S. Life-course-Betrachtung der häufigsten Kopfschmerzformen. Bundesgesundheitsbl. 57, 935–939 (2014). https://doi.org/10.1007/s00103-014-1995-3
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00103-014-1995-3